Solventum

What Solventum does

Solventum is an independent publicly traded healthcare company spun off from 3M's Health Care business in April 2024 and listed on the NYSE under ticker SOLV. Headquartered in Eagan, Minnesota, the company employs approximately 20,000 people globally and reported FY2025 net sales of $8.325 billion, with a market capitalization of approximately $12-13 billion as of early 2026. Following the September 2025 divestiture of its Purification & Filtration business to Thermo Fisher Scientific for $4.1 billion (which reduced debt from $8.3 billion to $4.2 billion), Solventum operates across three core segments: MedSurg (~60% of revenue), Dental (~15%+), and Health Information Systems (HIS, ~15%+).

The product portfolio is anchored by decades-old clinical franchises built on proprietary material science: V.A.C. Therapy and Prevena for negative pressure wound therapy (including reticulated open cell foam dressings), Tegaderm transparent dressings, Littmann stethoscopes, Filtek dental restoratives, Clarity clear aligners with Precision Grip Attachments and Digital Bonding, and Micropore surgical tapes. The HIS segment delivers Solventum 360 Encompass System, Fluency Direct voice-to-text transcription integrated with EHRs, and CDI Engage One for clinical documentation integrity. The December 2025 acquisition of Acera Surgical added Restrata electrospun fiber matrix technology for regenerative wound care. A $200 million Eagan Hub R&D center of excellence (opened April 2026) and a major Brookings, South Dakota manufacturing expansion target 20 new product innovations over two years.

Solventum's business model is B2B enterprise sales with quote-based pricing through direct sales teams and authorized distributor networks. The company serves hospitals, clinics, dental professionals, and health systems across more than 35 countries, with US sales accounting for 57.5% of total revenue. The recently launched Transform for the Future program targets $500 million in annual run-rate cost savings and 23-25% EBIT margins by FY2028, supported by a $1 billion share repurchase program approved in November 2025.

Name

Solventum

Legal name

Solventum Corporation

Website

https://solventum.com

Company type

Public

Founded year

2024

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Solventum is an independent publicly traded healthcare company spun off from 3M in April 2024, serving hospitals, dental professionals, and health systems globally with advanced wound care, surgical solutions, dental products, and health IT platforms across three operating segments.

Ownership category

akta.pro rank

Product category

Medical Devices and Healthcare Products

NAICS

Medical Equipment and Supplies Manufacturing (3391), Dental Equipment and Supplies Manufacturing (339114)

SIC

Surgical & Medical Instruments & Apparatus (3841), Dental Equipment & Supplies (3843)

akta.pro primary industry

Medical & Hygiene Disposables (Underpads, Disposable Washcloths, Bed Bath Products) (CRADALAK)

akta.pro secondary industries

Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening) (CRADAMAA), Adhesive, Sealant & Gasket Rubber Compounds (IMANAJAI)

Keywords

• Advanced wound care
• Negative pressure wound therapy
• Dental restoration materials
• Clinical documentation software
• Medical surgical supplies

Headquarters

HQ city

Minnesota City

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. MedSurg (Medical Surgical Products): Products for advanced wound care, surgical solutions, IV site management, sterilization assurance, patient monitoring and management. Approximately 60% of company revenue.
2. Dental Solutions: Dental restorative materials, orthodontic solutions including Clarity aligners and fixed appliances, preventive care products. Approximately 15%+ of revenue.
3. Health Information Systems (HIS): Healthcare IT software including ambient documentation, clinical documentation integrity, coding, population health analytics, and consulting services. Approximately 15%+ of revenue.
4. Purification & Filtration (Divested): Previously part of Solventum, this business was sold to Thermo Fisher Scientific for approximately $4.1 billion in September 2025.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

Solventum develops, manufactures, and sells medical surgical products (advanced wound care including V.A.C. Therapy and Prevena, surgical solutions, IV site management, sterilization assurance, and patient monitoring), dental solutions (Filtek restoratives, Clarity clear aligners, orthodontic appliances, preventive care), and health information systems software (Solventum 360 Encompass, Fluency Direct voice-to-text, CDI Engage One, coding and population health analytics) for hospitals, dental practices, and health systems globally.

Product overview

Solventum is a diversified healthcare company organized across four main segments: MedSurg (approximately 60% of revenue), Dental, Health Information Systems (HIS), and Purification & Filtration. The product portfolio includes advanced wound care solutions (V.A.C. Therapy, Prevena Therapy, Tegaderm dressings), oral care products (Clarity aligners, Filtek dental restoratives, Clinpro fluoride treatments), health IT platforms (Solventum 360 Encompass System, Fluency Direct, CDI Engage One), medical supplies (Littmann stethoscopes, surgical tapes, NG securement devices), and purification/filtration solutions. The company operates as a platform-plus-modules architecture with specialized product lines unified under corporate branding following its 2024 spinoff from 3M. The recent Acera Surgical acquisition adds synthetic tissue matrix technology to the wound care portfolio.

Differentiator

Problem solved

Functional benefit

Brands

• Clarity: Clear aligner orthodontic solution system including Clarity Aligners, Clarity Precision Grip Attachments, and Clarity Digital Bonding
• V.A.C. Therapy
• Prevena
• Filtek
• Tegaderm
• Littmann
• Fluency Direct
• CDI Engage One
• Solventum 360 Encompass
• Restrata

Products and services

• V.A.C. Therapy (Negative Pressure Wound Therapy) Advanced wound care system using controlled negative pressure (vacuum-assisted closure) to promote healing of chronic, acute, and traumatic wounds through tissue approximation, edema reduction, and granulation tissue formation. Targeted at hospitals, wound care clinics, and healthcare professionals.
• Prevena Therapy (Closed Incision Negative Pressure Therapy) Closed incision negative pressure therapy system with ROCF dressings that stabilizes closed surgical incisions, minimizes swelling, and reduces surgical site infections. FDA 510(k) cleared (Prevena 125 and Prevena Plus 125). Used by surgical teams and hospitals.
• Solventum Fluency Direct Voice-to-text clinical documentation solution integrated with electronic health record (EHR) systems, enabling physicians to dictate patient encounters and reduce administrative burden. Used by hospitals and health systems.
• Solventum CDI Engage One Clinical documentation integrity tool that helps physicians and CDI specialists ensure accurate, complete clinical documentation for proper coding and reimbursement. Targeted at hospital coding/CDI departments.
• Solventum 360 Encompass System Comprehensive health information platform offering clinical documentation, computer-assisted coding, revenue cycle management, and population health management capabilities for healthcare organizations.
• Clarity Aligners Clear orthodontic aligner system with Precision Grip Attachments and Digital Bonding workflow for teeth straightening, sold to orthodontists and dental practices.
• Filtek Dental Restoratives Dental restorative composite materials for direct and indirect dental restorative procedures, sold to dentists and dental laboratories.
• Clinpro Clear Fluoride Treatment Fluoride treatment product for preventive dental care applications, sold to dental professionals for caries prevention.
• Tegaderm Transparent Film Dressings Transparent film dressings and surgical drapes that provide a barrier against bacteria and viruses while allowing visualization of the wound site. Used in hospitals and clinical settings.
• Littmann Stethoscopes Professional-grade acoustic stethoscopes for patient assessment and monitoring across medical specialties, sold to clinicians, nurses, and medical schools globally.
• 2487 Hi-Tack Silicone Tape Medical adhesive tape designed for securement of medical wearable devices on patients with sensitive skin. Launched October 2024.
• 3M Nasogastric Securement Device Clear, skin-friendly adhesive nasogastric tube securement device designed to reduce pressure injuries and improve patient outcomes.
• Micropore Surgical Tape Breathable paper surgical tape for securing dressings and lightweight medical devices with gentle, hypoallergenic adhesion.
• Restrata Technology Platform Electrospun fiber matrix products for regenerative wound care and soft tissue reinforcement, including the FDA-approved Restrata MiniMatrix synthetic tissue matrix. Acquired through the December 2025 acquisition of Acera Surgical.

Quantifiable outcome

• Q1 FY2026 revenue $2.01 billion with 2.1% organic growth
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability7 records

Feature7 records

Partnerships

Three partnerships are on record, tiered core and minor.

• America's ToothFairycoreStrategic or Co-development Partner · 14 May 2026Solventum Foundation announced a $350,000 grant to America's ToothFairy to expand access to oral health screenings, dental education, and fluoride treatment for more than 100,000 children and caregivers in underserved communities over the next year. Solventum's dental business additionally donated 60,000 applications of 3M Clinpro Clear Fluoride Treatment to support the initiative.
• Thermo Fisher ScientificcoreStrategic or Co-development Partner · 1 February 2025Thermo Fisher Scientific acquired Solventum's Purification & Filtration business for approximately $4.1 billion in September 2025, strengthening Thermo Fisher's bioprocessing portfolio. This was a major strategic divestiture as part of Solventum's transformation plan.
• Siemens EnergyminorStrategic or Co-development PartnerPartnership with Siemens Energy to audit the Seefeld plant in Germany and implement sustainability plan including industrial heat pump installation expected to reduce greenhouse gas emissions by 17% (649 tons annually) with 6.5-year ROI and 30% government subsidy.

Scale indicators14 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Smith+Nephew: Global medical device company with overlapping advanced wound care portfolio including PICO single-use negative pressure wound therapy, directly competing with Solventum's V.A.C. and Prevena franchises in the same hospital channel.
• ConvaTec: Specialty medical products company focused on advanced wound management, ostomy care, and continence care, with direct overlap on negative pressure wound therapy and wound dressings sold to the same hospital customers as Solventum MedSurg.
• Mölnlycke Health Care: Swedish wound care and surgical solutions company whose Mepilex dressings, Avance negative pressure system, and surgical single-use instruments compete directly with Solventum's Tegaderm, V.A.C., and surgical drapes in acute care settings.
• Dentsply Sirona: Largest dental equipment and consumables manufacturer, competing directly with Solventum Dental in restorative materials, preventive care, and orthodontic bonding solutions sold through the same authorized dental distributor channel.
• Align Technology: Market-leading clear aligner company (Invisalign) that competes directly with Solventum's Clarity Aligners in the same orthodontic channel, with substantially greater scale, consumer brand recognition, and iTero scanner installed base.
• Envista Holdings: Dental products company with Nobel Biocare implants and Spark clear aligners that compete with both Solventum's Clarity aligners and Filtek restorative materials across the dental professional segment.
• Nuance Communications (Microsoft): Owner of Dragon Medical One, the dominant ambient speech-to-text clinical documentation solution directly competing with Solventum Fluency Direct within the Health Information Systems segment for EHR-integrated physician documentation spend.

Broad incumbents

• Becton, Dickinson and Company: Diversified medical technology company with overlapping IV site management (BD Nexiva), infection prevention, and surgical platforms serving the same hospital customers as Solventum MedSurg, though across a much broader portfolio.
• Stryker: Large medical device incumbent with overlapping surgical instruments, patient handling, and surgical equipment franchises sold to the same hospital procurement teams as Solventum, but at much greater scale and breadth.
• 3M Company: Former parent of Solventum with residual industrial overlap and ongoing 5-year post-spin share divestiture plan; 3M retains a stake and shared brand heritage in material science that creates both competitive overlap and residual governance considerations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/solventum
• YouTubeyoutube.com/@Solventum
• Facebookfacebook.com/solventumhealth
• LinkedInlinkedin.com/company/solventumhealth
• Instagraminstagram.com/solventumhealth

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solventum